Results 191 to 200 of about 11,049 (220)
Some of the next articles are maybe not open access.

Propofol in the treatment of refractory status epilepticus

Intensive Care Medicine, 2006
To study prospectively the effects of propofol anesthesia on seizure control, hemodynamics and course of intensive care in patients with refractory status epilepticus.Prospective observational study in the general intensive care unit in a tertiary university hospital.Ten patients with refractory status epilepticus.Patients received propofol anesthesia ...
Ilkka, Parviainen   +4 more
openaire   +2 more sources

Pentobarbital treatment of refractory status epilepticus

Neurology, 1987
We studied nine patients with status epilepticus refractory to standard therapy. In all patients so treated, IV pentobarbital terminated seizure activity. Mortality was high (77%) in those treated, but was attributed to underlying pathology and possibly to duration of status epilepticus.
M C, Rashkin, C, Youngs, P, Penovich
openaire   +2 more sources

Treatment strategies for refractory status epilepticus

Current Opinion in Critical Care, 2011
Status epilepticus is one of the most common emergencies in neurology, and every third patient does not respond to adequate first-line treatment. Refractory status epilepticus may be associated with increased morbidity and mortality, and new treatment options are urgently required.
openaire   +2 more sources

Midazolam in Refractory Status Epilepticus

Annals of Pharmacotherapy, 1996
D, Denzel, A H, Burstein
openaire   +2 more sources

Histopathology of new-onset refractory status epilepticus (NORSE) in adults

Seizure: the Journal of the British Epilepsy Association, 2021
Sandeep Mittal   +2 more
exaly  

Review and Updates on the Treatment of Refractory and Super Refractory Status Epilepticus

Journal of Clinical Medicine, 2021
Ayham Alkhachroum   +2 more
exaly  

Refractory Status Epilepticus

2023
Sonali Sen, James J. Riviello
openaire   +1 more source

Cryptogenic new-onset refractory status epilepticus responded to anti-interleukin-6 treatment

Journal of Neuroimmunology, 2022
Hideki Mochizuki   +2 more
exaly  

Home - About - Disclaimer - Privacy